Valeant bidding for Allergan.

How does Don F keep pulling this off?
Amazing!

 

Doesn't sound like it! Some companies value employees! Hard to believe when you work for the assholes at Valeant!

 

You seem to know exact numbers..Are you performing some kind of fellatio on him?

 

Ummm....isn't everyone performing exactly that either directly or indirectly while being employed at VRX.....just sayin'''

 

Something smells to high heaven when it comes to Valeant. Having been involved with many mergers/acquisitions it is obvious that newly merged companies need to undergo some type of transition process in order to harmonize their systems and processes. It's simply not feasible for this to be accomplished when a company like Valeant is on a buying spree akin to a kid in a candy store. Something must be sorely lacking and no surprise if there is gross state of non-compliance on all fronts:finance, safety reporting, clinical study monitoring, and overall regulatory maintenance for all these newly acquired products. It's only a matter of time ......

 

Look who they have in charge of safety reporting. Clinical studies? Do they have studies haha

 

Wake up Billy Bob, Pearson is taking advantage of a fat, overpaid, over staffed, wasteful industry - pharma. The cash flow from sales will continue without the majority of duplicative staff and everyone knows it, just too scared to do anything about it. Pearson doesn't have the history and "protective" mindset for all the hangers on in the industry.

 

JMP cares about only one thing: JMP

Wrongo, Mary Lou. Pearson is just another sociopath who is in it for the money, for the ego stroking, etc. He doesn't care about ANYTHING except his wealth and the recognition that will come with his success. VRX is a house of cards that will fall apart if not for the annual deals. ...and they will run out. Everyone knows it, but doesn't know when to take their $ and run.

If Allergan is fortunate enough to block the purchase by Valeant, Mike is going to be not so happy with all that egg on his face. The street is going to be not so happy, either, as they want their $$, too.

 

Re: JMP cares about only one thing: JMP

Wrong, it won't be the first deal he didnt win if this fails. But the Allergan CEO is out for himself too. Your old pharma world is over, get used to doing more with less like every other industry.

 

Ask to the employees of Bausch Lomb, if there is still some.

 

Re: JMP cares about only one thing: JMP

Wrong because it's a pyramid. He failed before when Valeant was smaller. Tick tick tick.

 

Re: JMP cares about only one thing: JMP

This isn't about doing more with less. This is about the decision to dismantle the research side of a pharma business. Pearson simply wants a buck. Same with his cronies and much of Wall Street. You may be on the winning side but at the expense of screwing over everyone else. That's just the truth.

 

Re: JMP cares about only one thing: JMP

Bullshit. You may be pissed about potentially losing your job, but that is NOT a crisis for the rest of the world.

 

I work for AGN and just found out that VRX launched 19 products last yr with a 'limited' R and D team, that's more than we launched for sure! Maybe this is the model of the future! God knows our shareholders and exec team will be on the winning end of this merger but Godspeed to all the other employees! I am most upset with the lack of transparency from our own company! Totally gutless if you ask me! Original bid went in 19 months ago and my 5th grader can get around our 'poison pill!' Wtf!

 

More like you are a Valeant employee who is drinking the cool-aid and getting more stock than you deserve.

Launches are due to acquisitions or are cosmetics. VRX likes to play with math.

AGN, like all companies, shares material discussions. Also, no offer was tendered a year or so ago because it was all talk.

The reason why VRX came out with it first is because they announced it BEFORE providing it to AGN, and it's a hostile attempt. Again, nice gamesmanship VRX, as it does make AGN look like they are hiding something. AGN has never been open to acquisition from VRX.

DP will do everything he can, as limiited as it is, to sell to someone other than JMP, and then poof, watch VRX's stock go down, down, down. Good luck finding another well-resourced pharma company of this size that Ackman will help with. At this point in VRX history, failure is not a reasonable option.

 

VRX launched 19 products last year!! Do tell what products? Do you know what it takes to launch a product?! Acquiring a product is not a launch you fucking moron.

 

First of all, it is 19 products to be launched in 2014.

Secondly, the Valeant reps are fine because the AGN reps make more base salary (beginning at 80k plus 26k in bonus).

Thirdly, company cars will change to Prius for gas purposes.

 

Just because WalMart can bid for Neiman Marcus doesn't mean it's a good fit.

 

Funny that AGN wants no part of Valeant that they are trying to buy Shire to keep you all away.

 

http://www.cafepharma.com/boards/showthread.php?t=556370

Valeant;s partnership to purchase a company is a new move that everyone is going to now work against. It takes current law and stretches it to the legal/ethical limits.

Government, Communities, employees, CEOs, are now all on guard for this new game. Now the partner hopes more biders come in for Allergan and their stock will rise even higher. The problem is that the game relies on other company CEOs to jump in and make the higher bid. Good companies do not have time for these games and will steer clear.

Also, Allergan and Allergan share holders will compare the bid to the relative value of Allergan stock long-term and determine that the bid is not good enough. The partner will get frustrated as Allergan rejects the takeover and as the short term stock price moves lower it will start to sell and lower its 10% stake. Ultimately they may lose money on this in your face aren't we smart - play on the financial community.

Valeant will gain nothing on this attempted hostile take over. Now everyone (banks included) will now know how far Valeant will go to stretch the currently accepted rules and practices in the financial community and may look at giving out new loans with needed skepticism.

If you try to play a game by your own rules the other players in the game may just pick up and go home.